Reckitt Benckiser has filed an appeal against GlaxoSmithKline, after a judge found the consumer goods giant misled consumers with claims that Nurofen was a more effective pain killer than its rival’s Panadol and ordered it to pay all of GlaxoSmithKline’s legal bill.
Game-changing ruling finds Spotless workers owed redundancy
Murray Goulburn class goes digging for Herbert Smith docs
ASIC sues Rio Tinto and former execs
The Australian Securities and Investments Commission has lodged a case in Federal Court against Rio Tinto, its former CEO and former CFO over allegedly misleading market statements it made about the reserves of a recent $4 billion acquisition, a controversy that has already landed the mining giant in hot water with regulators in the UK and US.